LLNL Researchers Unveil Novel Insights on Humidity's Role in Aluminum Corrosion Using Ruby Supercomputer
Jan 12, 2024Stochastic optimization of a uranium oxide reaction mechanism using plasma flow reactor measurements
Jan 11, 2024Study shows toothpaste with ‘artificial enamel’ ingredient restores enamel, is more effective than fluoride
May 03, 2023What is Lithium Carbonate? (Updated 2023)
Oct 15, 2023Open consultation on cobalt sulfate, spodumene, graphite price assessments
Aug 03, 2023Selphyl is Unveiled as a Revolutionary PRFM System, Pioneering a New Era in Aesthetics and Orthopedic Medicine
NEWTOWN, PA - (NewMediaWire) - June 5, 2023 - Selphyl(TM) is a groundbreaking and revolutionary technology for platelet-rich fibrin therapy. The company has unveiled its state-of-the-art Selphyl(TM) Platelet-Rich Fibrin Matrix (PRFM) system, meticulously engineered to enhance the safety, precision, and efficiency of extracting Platelet-Rich Plasma from blood samples for a variety of medical procedures.
In their product announcement, Factor Medical emphasized a common issue with traditional PRP extraction systems, which often rely heavily on operator skills, resulting in inconsistent results and potential contamination from red and white blood cells. Selphyl(TM), on the other hand, effectively addresses this concern by virtually removing all contaminated cells from the blood, regardless of the technique employed. By adopting this approach, medical treatment providers and physicians can achieve a standardized outcome in PRP extraction to PRFM, protecting and preserving platelets, independent of the operator's expertise.
Further explaining its PRFM System, the company noted that the PRP extracted from the blood is carefully transformed into a Platelet Rich Fibrin Matrix using a controlled process. This unique matrix acts as a protective scaffold, ensuring the preservation and integrity of the platelets throughout the medical treatment.
Speaking on how and why their product is different, the company's spokesperson said: "The SELPHYL(R) System is a completely closed system and can convert PRP to PRFM with the aseptic transfer of the PRP into the second blood tube containing a precise amount of calcium chloride. This step initiates the conversion of fibrinogen to fibrin, as part of the clotting cascade. The fibrin matrix serves as a three-dimensional scaffold to maintain the platelets at the site of injection. The scaffold also serves to protect the platelets so their release of growth factors can be sustained over a longer period of time."
By using the new and FDA-cleared PRFM system, the company notes that clinicians and physicians will now be able to deliver better benefits to their clients while reducing the complexities associated with extracting PRP from blood. The revolutionary kit offers many other key advantages, including superior technology that can help medical professionals deliver improved results to patients, thus driving their client success rate and improving their reputation.
The innovative system utilizes a fully closed design, effectively safeguarding the integrity of the extracted platelets and creating a denser fibrin matrix by adding additional factors to the platelet concentrate.
Physicians, clinicians, and their patients can also enjoy additional benefits like guaranteed ultrapure Platelet-Rich Fibrin Matrix when instructions for use are followed, operator skills and technique-independent outcomes, viable platelets, and sustained platelet growth factor release for days after application.
The company has placed a strong emphasis on the safety of its Selphyl(TM) product, conducting extensive clinical safety evaluations to ensure its suitability for use in the medical industry. The introduction of the Selphyl(TM) revolutionary PRFM System addresses numerous key concerns.
According to the company's spokesperson, their extraction kit has been specifically designed to reduce the PRP extraction time to approximately 20 minutes. This faster and simpler procedure enables physicians and clinicians to accommodate a larger number of patients compared to the traditional extraction methods.
The company's spokesperson also noted that the kit does not affect the number of treatment sessions a patient may need. He noted that medical professionals will be able to determine the required treatment sessions based on their patient's personal needs and expected outcomes.
Factor Medical also noted that its advanced PRFM extraction kit stands out due to its close-to-physiological pH, setting it apart from other products with lower pH or higher acidity levels. The extraction kit also has an exemplary safety history, making it a premier choice for physicians, clinicians, and patients.
Factor Medical welcomes physicians, clinicians, and medical personnel interested in becoming providers of their innovative PRFM system. Those interested can visit the Selphyl(TM) website, where they can access the "Become A Provider" section and fill in their details. The dedicated team at Factor Medical will promptly get in touch with them to initiate the next steps in the process.
Media Contact:
Company Name: Factor Medical Inc. / Selphyl
Contact Person: Kristin Shuffler
Phone: (267) 391 - 9685
Address: 12 Penns Trail
City: Newtown
State: PA
Postal Code: 18940
Country: US
Website: https://www.selphyl.com/